Learn more on this topic: Risk Stratification in Multiple Myeloma: Putting the Pieces Together

What is the best strategy for managing minimal residual disease?

Hans C. Lee, MD

Hans C. Lee, MD, on risk stratification in multiple myeloma.

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.